Hikma Pharmaceuticals Plc Holding(s) in Company (6889E)
09 Novembre 2020 - 12:38PM
UK Regulatory
TIDMHIK
RNS Number : 6889E
Hikma Pharmaceuticals Plc
09 November 2020
TR-1: Standard form for notification of major holdings
LONDON, 9 November 2020 - Hikma Pharmaceuticals PLC (LEI:549300BNS685UXH4JI75)
(LSE: HIK) (NasdaqDubai: HIK) (LSE: HIK) announces as follows:
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer
and to the FCA in Microsoft Word format if possible)
1a. Identity of the issuer or the Hikma Pharmaceuticals PLC
underlying issuer of existing shares
to which voting rights are attached:
1b. Please indicate if the issuer is a non-UK issuer (please mark
with an "X" if appropriate)
Non-UK issuer
--------
2. Reason for the notification (please mark the appropriate box
or boxes with an "X")
An acquisition or disposal of voting rights X
--------
An acquisition or disposal of financial instruments
--------
An event changing the breakdown of voting rights
--------
Other (please specify):
--------
3. Details of person subject to the notification obligation
Name Wellington Management Group LLP
-----------------------------------------------
City and country of registered Boston, USA
office (if applicable)
-----------------------------------------------
4. Full name of shareholder(s) (if different from 3)
Name Bank of New York (Nominees)
Ltd
BBH ISL NOMINEES LTD
BNY (OCS) Nominees Limited
GOLDMAN SACHS INTERNATIONAL
HSBC Global Custody Nominee
(UK) Limited
Japan Trustee Services Bank
Ltd.
JP Morgan Chase Nominees
Limited
Mellon Nominees (UK) Ltd.
Nortrust Nominees Limited
ROY Nominees Limited
State Street Nominees Limited
VIDACOS NOMINEES LIMITED
-----------------------------------------------
City and country of registered
office (if applicable)
-----------------------------------------------
5. Date on which the threshold 05/11/2020
was crossed or reached:
-----------------------------------------------
6. Date on which issuer notified 06/11/2020
(DD/MM/YYYY):
-----------------------------------------------
7. Total positions of person(s) subject to the notification obligation:
% of voting % of voting rights Total of both Total number
rights attached through financial in % of voting rights
to shares instruments of issuer
(total of (total of 8.B.1 (8.A + 8.B)
8.A) + 8.B.2)
----------------- --------------------- -------------- --------------------
Resulting situation
on the date on
which threshold
was crossed or
reached 5.00% 0.01% 5.01% 230,496,614
----------------- --------------------- -------------- --------------------
Position of previous
notification
(if applicable)
----------------- --------------------- -------------- --------------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached:
A: Voting rights attached to shares
Class/type Number of voting rights % of voting rights
of shares
ISIN code
(if possible)
---------------------------------------------------------------- --------------------------------
Direct Indirect Direct Indirect
(Art 9 of (Art 10 of Directive (Art 9 (Art 10 of
Directive 2004/109/EC) (DTR5.2.1) of Directive Directive
2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.1) (DTR5.2.1)
--------------- ----------------------------------------------- --------------- ---------------
GB00B0LCW083
Common Stock 11,522,905 5.00%
--------------- ----------------------------------------------- --------------- ---------------
SUBTOTAL 8.A 11,522,905 5.00%
---------------------------------------------------------------- --------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive
2004/109/EC (DTR5.3.1.1 (a))
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that may be rights
instrument Period acquired if the instrument
is exercised/converted
--------------- ------------------------ -------------------------------------- ---------------
SUBTOTAL
8.B.1
-------------------------------------- ---------------
B 2: Financial Instruments with similar economic effect according
to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical Number of % of voting
financial date Conversion or cash voting rights rights
instrument Period settlement
--------------- ------------------------ ----------------- ------------------- ---------------
6,615 Equity
Swap shares
or 6,615
votes on
a converted
Equity Swap 22/05/2023 08/10/2018to22/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
4,378 Equity
Swap shares
or 4,378
votes on
a converted
Equity Swap 15/05/2023 02/03/2018to15/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
4,019 Equity
Swap shares
or 4,019
votes on
a converted
Equity Swap 15/05/2023 10/10/2017to15/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
1,931 Equity
Swap shares
or 1,931
votes on
a converted
Equity Swap 22/05/2023 05/10/2018to22/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
1,455 Equity
Swap shares
or 1,455
votes on
a converted
Equity Swap 15/05/2023 16/07/2018to15/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
1,450 Equity
Swap shares
or 1,450
votes on
a converted
Equity Swap 15/05/2023 02/02/2018to15/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
1,434 Equity
Swap shares
or 1,434
votes on
a converted
Equity Swap 22/05/2023 08/01/2019to22/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
1,376 Equity
Swap shares
or 1,376
votes on
a converted
Equity Swap 15/05/2023 02/07/2018to15/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
1,317 Equity
Swap shares
or 1,317
votes on
a converted
Equity Swap 22/05/2023 03/07/2018to22/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
1,156 Equity
Swap shares
or 1,156
votes on
a converted
Equity Swap 15/05/2023 23/10/2017to15/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
1,138 Equity
Swap shares
or 1,138
votes on
a converted
Equity Swap 15/05/2023 11/06/2018to15/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
1,134 Equity
Swap shares
or 1,134
votes on
a converted
Equity Swap 22/05/2023 15/07/2019to22/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
1,124 Equity
Swap shares
or 1,124
votes on
a converted
Equity Swap 22/05/2023 05/04/2018to22/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
956 Equity
Swap shares
or 956 votes
on a converted
Equity Swap 05/05/2023 10/09/2020to05/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
871 Equity
Swap shares
or 871 votes
on a converted
Equity Swap 05/05/2023 11/09/2020to05/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
1,289 Index
Future shares
or 840 votes
on a converted
Index Future 05/11/2020 01/01/1900to05/11/2020 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
709 Equity
Swap shares
or 709 votes
on a converted
Equity Swap 15/05/2023 27/07/2018to15/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
517 Equity
Swap shares
or 517 votes
on a converted
Equity Swap 15/05/2023 26/03/2018to15/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
445 Equity
Swap shares
or 445 votes
on a converted
Equity Swap 15/05/2023 16/04/2018to15/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
291 Equity
Swap shares
or 291 votes
on a converted
Equity Swap 05/05/2023 30/07/2018to05/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
249 Equity
Swap shares
or 249 votes
on a converted
Equity Swap 05/05/2023 24/09/2020to05/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
197 Equity
Swap shares
or 197 votes
on a converted
Equity Swap 05/05/2023 24/09/2020to05/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
193 Equity
Swap shares
or 193 votes
on a converted
Equity Swap 05/05/2023 09/09/2020to05/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
177 Equity
Swap shares
or 177 votes
on a converted
Equity Swap 15/05/2023 18/06/2018to15/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
5 Equity
Swap shares
or 5 votes
on a converted
Equity Swap 05/05/2023 24/09/2020to05/05/2023 Cash settlement basis 0.00%
--------------- ------------------------ ----------------- ------------------- ---------------
SUBTOTAL
8.B.2 33,977 0.01%
------------------- ---------------
9. Information in relation to the person subject to the notification
obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control
any other undertaking(s) holding directly or indirectly an
interest in the (underlying) issuer.
Full chain of controlled undertakings through which the voting X
rights and/or the financial instruments are effectively held
starting with the ultimate controlling natural person or legal
entity (please add additional rows as necessary)
--------
Name % of voting rights % of voting rights Total of both
if it equals through financial if it equals
or is higher instruments if or is higher
than the notifiable it equals or than the notifiable
threshold is higher than threshold
the notifiable
threshold
----------------------- --------------------- --------------------------
Wellington Management
Group LLP 5.01%
--------------------------------------------- --------------------------
Wellington Group Holdings
LLP 5.01%
--------------------------------------------- --------------------------
Wellington Investment
Advisors Holdings
LLP 5.01%
--------------------------------------------- --------------------------
Wellington Management
Company LLP
----------------------- --------------------- --------------------------
Wellington Management
Group LLP 5.01%
--------------------------------------------- --------------------------
Wellington Group Holdings
LLP 5.01%
--------------------------------------------- --------------------------
Wellington Investment
Advisors Holdings
LLP 5.01%
--------------------------------------------- --------------------------
Wellington Management
Global Holdings, Ltd.
--------------------------------------------- --------------------------
Wellington Management
International Ltd
--------------------------------------------- --------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
-------------------------------------------------
The number and % of voting rights
held
-------------------------------------------------
The date until which the voting
rights will be held
-------------------------------------------------
11. Additional information:
Place of completion Boston, MA USA
Date of completion 06/11/2020
------------------------------------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLUKOARRVUARAA
(END) Dow Jones Newswires
November 09, 2020 06:38 ET (11:38 GMT)
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Apr 2023 a Apr 2024